Skip to main content

Table 1 PNI and clinicopathological characteristics relationship

From: The role of prognostic nutritional index in the management of pulmonary sarcomatoid carcinoma

Variables

Cases (n)

PNI (mean ± SD)

P-value

Sex

0.084

 Male

69

48.83 ± 5.89

 Female

22

51.19 ± 4.07

Age (years)

0.170

 ≤ 60

51

50.11 ± 5.66

 > 60

40

48.49 ± 5.39

Smoking history

0.692

 Former/current smoker

51

49.19 ± 5.98

 Never-smoker

40

49.66 ± 5.07

Alcohol abuse

0.615

 Yes

37

49.04 ± 6.05

 No

54

49.65 ± 5.26

Histologic subtype

0.919

 Giant/spindle cell carcinoma

87

49.41 ± 5.60

 Other subtype

4

49.12 ± 5.81

Tumor size (cm)

0.120

 ≤ 5

38

50.48 ± 5.82

 > 5

53

48.63 ± 5.31

Tumor stage

0.008

 T1–2

31

51.53 ± 5.23

 T3–4

60

48.30 ± 5.46

Tumor location

0.670

 Peripheral

37

48.76 ± 6.04

 Central

9

49.78 ± 4.42

 Both

45

49.85 ± 5.43

Nodal metastasis

0.048

 N0

54

50.35 ± 5.68

 N1–3

37

48.01 ± 5.17

Pathological stage(8th edition)

0.001

 Ia–IIa

34

51.96 ± 5.31

 IIb–IIIc

57

47.88 ± 5.19

Treatment modality

0.959

 Surgery

31

47.97 ± 5.28

 Surgery + adjuvant CT

30

51.27 ± 5.46

 Surgery + adjuvant CT + targeted therapy

30

49.00 ± 5.63

  1. PNI: prognostic nutrition index, SD: Standard deviation. CT: chemotherapy